Since 1996 Index Ventures has invested in seed and early stage start-ups. Now it says Europe’s start-ups are more mature and need care and capital to stay in control.
By all means focus on funding – but let’s spend more on fundamentally redesigning educational systems: less energy on testing outdated models and more on trying new technologies.
Alexander von Gabain and his team laid the foundations of an enterprise that would rise to the top of the continent’s biotechnology pile – and rewrite the region’s rules for biotechnology start-ups.